Search Results

There are 115281 results for: content related to: Advances in therapies for acute promyelocytic leukemia

  1. You have free access to this content
    Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer

    Journal of Internal Medicine

    Volume 278, Issue 6, December 2015, Pages: 627–642, J.-Q. Mi, S.-J. Chen, G.-B. Zhou, X.-J. Yan and Z. Chen

    Version of Record online : 9 JUN 2015, DOI: 10.1111/joim.12376

  2. Current standard treatment of adult acute promyelocytic leukaemia

    British Journal of Haematology

    Volume 172, Issue 6, March 2016, Pages: 841–854, Francesco Lo-Coco, Laura Cicconi and Massimo Breccia

    Version of Record online : 21 DEC 2015, DOI: 10.1111/bjh.13890

  3. You have free access to this content
    Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel

    British Journal of Haematology

    Volume 175, Issue 4, November 2016, Pages: 588–601, Oussama Abla, Matthew A. Kutny, Anna Maria Testi, James H. Feusner, Ursula Creutzig, John Gregory Jr, Brenda Gibson, Guy Leverger, Raul C. Ribeiro, Owen Smith, Franco Locatelli and Gertjan Kaspers

    Version of Record online : 21 SEP 2016, DOI: 10.1111/bjh.14313

  4. The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy

    Cancer

    Volume 122, Issue 8, April 15, 2016, Pages: 1160–1168, Lorenzo Falchi, Srdan Verstovsek, Farhad Ravandi-Kashani and Hagop M. Kantarjian

    Version of Record online : 30 DEC 2015, DOI: 10.1002/cncr.29852

  5. You have free access to this content
    How I treat children and adolescents with acute promyelocytic leukaemia

    British Journal of Haematology

    Volume 164, Issue 1, January 2014, Pages: 24–38, Oussama Abla and Raul C. Ribeiro

    Version of Record online : 30 SEP 2013, DOI: 10.1111/bjh.12584

  6. You have free access to this content
    The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission

    Intervention Review

    The Cochrane Library

    Eli Muchtar, Liat Vidal, Ron Ram, Anat Gafter-Gvili, Ofer Shpilberg and Pia Raanani

    Published Online : 28 MAR 2013, DOI: 10.1002/14651858.CD009594.pub2

  7. You have free access to this content
    Bleeding and thrombosis in acute promyelocytic leukemia

    American Journal of Hematology

    Volume 87, Issue 6, June 2012, Pages: 596–603, Aditi Choudhry and Thomas G. DeLoughery

    Version of Record online : 1 MAY 2012, DOI: 10.1002/ajh.23158

  8. You have free access to this content
    The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

    British Journal of Haematology

    Volume 156, Issue 1, January 2012, Pages: 24–36, Karen A. Breen, David Grimwade and Beverley J. Hunt

    Version of Record online : 3 NOV 2011, DOI: 10.1111/j.1365-2141.2011.08922.x

  9. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia

    Hematological Oncology

    Volume 32, Issue 1, March 2014, Pages: 40–46, Yinjun Lou, Wenbin Qian, Haitao Meng, Wenyuan Mai, Hongyan Tong, Yin Tong, Jian Huang and Jie Jin

    Version of Record online : 20 AUG 2013, DOI: 10.1002/hon.2076

  10. Differentiation Therapy

    Standard Article

    Holland-Frei Cancer Medicine

    Sai-Juan Chen, Xiao-Jing Yan, Guang-Biao Zhou and Zhu Chen

    Published Online : 26 FEB 2017, DOI: 10.1002/9781119000822.hfcm011

  11. Dose-adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 331–335, Frank Firkin, Fernando Roncolato and Wai Khoon Ho

    Version of Record online : 23 MAR 2015, DOI: 10.1111/ejh.12502

  12. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada

    European Journal of Haematology

    Volume 95, Issue 3, September 2015, Pages: 218–229, Jean Lachaine, Karine Mathurin, Stéphane Barakat and Stephen Couban

    Version of Record online : 4 FEB 2015, DOI: 10.1111/ejh.12475

  13. You have free access to this content
    Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia

    British Journal of Haematology

    Volume 128, Issue 6, March 2005, Pages: 853–862, William Matsui, B. Douglas Smith, Milada Vala, Nikeshia Beal, Carol Ann Huff, Louis F. Diehl and Richard J. Jones

    Version of Record online : 8 MAR 2005, DOI: 10.1111/j.1365-2141.2005.05395.x

  14. You have free access to this content
    Cardiac monitoring of patients receiving arsenic trioxide therapy

    British Journal of Haematology

    Volume 124, Issue 5, March 2004, Pages: 610–617, Dilip Unnikrishnan, Janice P. Dutcher, Susan Garl, Nikita Varshneya, Richard Lucariello and Peter H. Wiernik

    Version of Record online : 2 FEB 2004, DOI: 10.1111/j.1365-2141.2003.04817.x

  15. You have free access to this content
    Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

    International Journal of Cancer

    Volume 125, Issue 2, 15 July 2009, Pages: 264–275, Pablo E. Vivas-Mejía, Bulent Ozpolat, Xian Chen and Gabriel Lopez-Berestein

    Version of Record online : 6 FEB 2009, DOI: 10.1002/ijc.24341

  16. Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia

    European Journal of Haematology

    Volume 93, Issue 1, July 2014, Pages: 54–62, Xianmin Song, Xiaoxia Hu, Shuqing Lü, Lei Gao, Li Chen, Jianmin Yang, Weiping Zhang and Jianmin Wang

    Version of Record online : 1 APR 2014, DOI: 10.1111/ejh.12301

  17. You have full text access to this Open Access content
    Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma

    Cancer Science

    Volume 101, Issue 4, April 2010, Pages: 975–983, Hongchi Jiang, Yong Ma, Xiaoning Chen, Shangha Pan, Bei Sun, Geoffrey W. Krissansen and Xueying Sun

    Version of Record online : 9 DEC 2009, DOI: 10.1111/j.1349-7006.2009.01464.x

  18. You have free access to this content
    Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia

    Cancer

    Volume 119, Issue 1, 1 January 2013, Pages: 115–125, Yingmei Zhang, Zhuo Zhang, Jinmei Li, Limin Li, Xueying Han, Lina Han, Longhu Hu, Shuye Wang, Yanhong Zhao, Xiaoxia Li, Ying Zhang, Shengjin Fan, Chengfang Lv, Yinghua Li, Yanhua Su, Hui Zhao, Xin Zhang and Jin Zhou

    Version of Record online : 28 AUG 2012, DOI: 10.1002/cncr.27650

  19. PML/RARα fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase

    Journal of Cellular Physiology

    Volume 217, Issue 2, November 2008, Pages: 486–493, Lingna Li, Jie Wang, Richard D. Ye, Guiying Shi, Huifang Jin, Xueming Tang and Jing Yi

    Version of Record online : 17 JUL 2008, DOI: 10.1002/jcp.21523

  20. You have free access to this content
    Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1057–1064, Hyun Joo Jung, Zheng Chen and Nami McCarty

    Version of Record online : 11 SEP 2012, DOI: 10.1002/ajh.23317